By Regulatory Approvals — FDA Clears IND for ADI-212, a PSMA-Targeted CAR T, in mCRPC Targeted Oncology
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 29, 2026.